These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group. Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074 [TBL] [Abstract][Full Text] [Related]
50. Crohn's disease and acute leukocytoclastic vasculitis of skin. Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427 [TBL] [Abstract][Full Text] [Related]
52. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid]. Fahrländer H Schweiz Med Wochenschr; 1987 Oct; 117(42):1620-3. PubMed ID: 3321418 [TBL] [Abstract][Full Text] [Related]
53. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease]. Hartmann F Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082 [No Abstract] [Full Text] [Related]
54. IBD: which 5-ASA drug works where? Ferry GD J Pediatr Gastroenterol Nutr; 1993 May; 16(4):474-5. PubMed ID: 8315560 [No Abstract] [Full Text] [Related]
55. [Salicylates in the treatment of Crohn disease]. Mangiarotti R; Prantera C Ann Ital Chir; 1994; 65(3):279-81. PubMed ID: 7887577 [No Abstract] [Full Text] [Related]
56. Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. Feagan BG; McDonald JW; Rochon J; Laupacis A; Fedorak RN; Kinnear D; Saibil F; Groll A; Archambault A; Gillies R N Engl J Med; 1994 Jun; 330(26):1846-51. PubMed ID: 8196727 [TBL] [Abstract][Full Text] [Related]